BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29557843)

  • 1. A Xenograft Model of Vestibular Schwannoma and Hearing Loss.
    Dinh CT; Bracho O; Mei C; Bas E; Fernandez-Valle C; Telischi F; Liu XZ
    Otol Neurotol; 2018 Jun; 39(5):e362-e369. PubMed ID: 29557843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An allograft mouse model for the study of hearing loss secondary to vestibular schwannoma growth.
    Bonne NX; Vitte J; Chareyre F; Karapetyan G; Khankaldyyan V; Tanaka K; Moats RA; Giovannini M
    J Neurooncol; 2016 Aug; 129(1):47-56. PubMed ID: 27177628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.
    Chen J; Landegger LD; Sun Y; Ren J; Maimon N; Wu L; Ng MR; Chen JW; Zhang N; Zhao Y; Gao X; Fujita T; Roberge S; Huang P; Jain RK; Plotkin SR; Stankovic KM; Xu L
    Nat Protoc; 2019 Feb; 14(2):541-555. PubMed ID: 30617350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of AR42 in Primary Vestibular Schwannoma Cells and a Xenograft Model of Vestibular Schwannoma.
    Misztal C; Bracho O; Bas E; Estivill M; Ivan ME; Morcos J; Bhatia R; Telischi F; Liu XZ; Gultekin SH; Fernandez-Valle C; Dinh CT
    Otol Neurotol; 2022 Jul; 43(6):694-701. PubMed ID: 35761463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models.
    Zhao Y; Liu P; Zhang N; Chen J; Landegger LD; Wu L; Zhao F; Zhao Y; Zhang Y; Zhang J; Fujita T; Stemmer-Rachamimov A; Ferraro GB; Liu H; Muzikansky A; Plotkin SR; Stankovic KM; Jain RK; Xu L
    Proc Natl Acad Sci U S A; 2018 Feb; 115(9):E2077-E2084. PubMed ID: 29440379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation.
    Gehlhausen JR; Park SJ; Hickox AE; Shew M; Staser K; Rhodes SD; Menon K; Lajiness JD; Mwanthi M; Yang X; Yuan J; Territo P; Hutchins G; Nalepa G; Yang FC; Conway SJ; Heinz MG; Stemmer-Rachamimov A; Yates CW; Wade Clapp D
    Hum Mol Genet; 2015 Jan; 24(1):1-8. PubMed ID: 25113746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescent Detection of Merlin-deficient Schwann Cells and Primary Human Vestibular Schwannoma Cells Using Sodium Fluorescein.
    Perez ER; Bracho O; Ein L; Szczupak M; Monje PV; Fernandez-Valle C; Alshaiji A; Ivan M; Morcos J; Liu XZ; Hoffer M; Eshraghi A; Angeli S; Telischi F; Dinh CT
    Otol Neurotol; 2018 Sep; 39(8):1053-1059. PubMed ID: 30001282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumors of the nervous system and hearing loss: Beyond vestibular schwannomas.
    Ruiz-García C; Lassaletta L; López-Larrubia P; Varela-Nieto I; Murillo-Cuesta S
    Hear Res; 2024 Jun; 447():109012. PubMed ID: 38703433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of sporadic and neurofibromatosis type 2-associated vestibular schwannoma growth in vitro and in vivo after treatment with the c-Jun N-terminal kinase inhibitor AS602801.
    Dougherty MC; Shibata SB; Clark JJ; Canady FJ; Yates CW; Hansen MR
    J Neurosurg; 2023 Apr; 138(4):962-971. PubMed ID: 36087315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2.
    Choi JW; Lee JY; Phi JH; Wang KC; Chung HT; Paek SH; Kim DG; Park SH; Kim SK
    J Neurosurg Pediatr; 2014 Jun; 13(6):650-7. PubMed ID: 24724714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
    Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
    Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merlin status regulates p75(NTR) expression and apoptotic signaling in Schwann cells following nerve injury.
    Ahmad I; Fernando A; Gurgel R; Jason Clark J; Xu L; Hansen MR
    Neurobiol Dis; 2015 Oct; 82():114-122. PubMed ID: 26057084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model.
    Gao X; Zhao Y; Stemmer-Rachamimov AO; Liu H; Huang P; Chin S; Selig MK; Plotkin SR; Jain RK; Xu L
    Proc Natl Acad Sci U S A; 2015 Nov; 112(47):14676-81. PubMed ID: 26554010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric cerebellopontine angle and internal auditory canal tumors: clinical article.
    Holman MA; Schmitt WR; Carlson ML; Driscoll CL; Beatty CW; Link MJ
    J Neurosurg Pediatr; 2013 Oct; 12(4):317-24. PubMed ID: 23909617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auditory brainstem implants for neurofibromatosis type 2.
    Colletti L; Shannon R; Colletti V
    Curr Opin Otolaryngol Head Neck Surg; 2012 Oct; 20(5):353-7. PubMed ID: 22886036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
    Carlson ML; Breen JT; Driscoll CL; Link MJ; Neff BA; Gifford RH; Beatty CW
    Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2.
    Samii M; Matthies C; Tatagiba M
    Neurosurgery; 1997 Apr; 40(4):696-705; discussion 705-6. PubMed ID: 9092842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cochlear implants in the management of hearing loss in Neurofibromatosis Type 2.
    Harris F; Tysome JR; Donnelly N; Durie-Gair J; Crundwell G; Tam YC; Knight RD; Vanat ZH; Folland N; Axon P
    Cochlear Implants Int; 2017 May; 18(3):171-179. PubMed ID: 28335700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of vestibular schwannomas and hearing loss in NF2 patients.
    Peyre M; Bernardeschi D; Sterkers O; Kalamarides M
    Neurochirurgie; 2018 Nov; 64(5):342-347. PubMed ID: 26183546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.